Thermo Fisher Scientific Inc. Third Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Thermo Fisher Scientific, Inc. (NYSE:TMO) will unveil its latest earnings on Wednesday, October 26, 2011. Thermo Fisher Scientific develops, manufactures and sells products to assist the pharmaceutical, biotechnology, academic, government and other research and industrial markets.

Thermo Fisher Scientific, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.07 per share, a rise of 18.9% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.06. Between one and three months ago, the average estimate was unchanged. It has risen during the last month. Analysts are projecting profit to rise by 17.6% versus last year to $4.20.

Past Earnings Performance: Last quarter, the company beat estimates by one cent, coming in at profit of 99 cents a share versus the estimate of net income of 98 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: Analysts are projecting a rise of 11.9% in revenue from the year-earlier quarter to $3 billion.

Analyst Ratings: Analysts are bullish on this stock with 14 analysts rating it as a buy, none rating it as a sell and none rating it as a hold.

A Look Back: In the second quarter, profit rose more than twofold to $523.4 million ($1.36 a share) from $237.3 million (57 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 9.4% to $2.9 billion from $2.65 billion.

Key Stats:

The company has seen net income rise in three straight quarters. Net income rose 8.6% in the first quarter and 8.9% in the fourth quarter of the last fiscal year.

The company’s revenue has risen for two straight quarters. In the first quarter, the figure rose 1.7%.

Competitors to Watch: PerkinElmer, Inc. (NYSE:PKI), Becton, Dickinson and Co. (NYSE:BDX), Bruker Corporation (NASDAQ:BRKR), Beckman Coulter, Inc. (NYSE:BEC), Harvard Bioscience, Inc. (NASDAQ:HBIO), Bio-Rad Laboratories, Inc. (NYSE:BIO), CareFusion Corporation (NYSE:CFN), Waters Corporation (NYSE:WAT), Teleflex Incorporated (NYSE:TFX), and Quidel Corporation (NASDAQ:QDEL).

Stock Price Performance: During July 27, 2011 to October 20, 2011, the stock price had fallen $8.13 (-13.5%) from $60.03 to $51.90. The stock price saw one of its best stretches over the last year between May 5, 2011 and May 16, 2011 when shares rose for eight-straight days, rising 4.3% (+$2.59) over that span. It saw one of its worst periods between March 11, 2011 and March 18, 2011 when shares fell for six-straight days, falling 4.8% (-$2.67) over that span. Shares are down $3.46 (-6.3%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.